Cardiology Update
/
RSS Feed
The DanGer Shock trial assessed the efficacy of the Impella CP ventricular assist device in reducing mortality following myocardial infarction (MI). In this episode, Dr. Chadi Alraies discusses this important trial with the principal investigator, Professor Jacob Møller.
For more cardiology research news join our newsletter or follow us on Twitter, Facebook, LinkedIn or Instagram.